Federated Hermes’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.3M | Buy |
4,599,450
+513,870
| +13% | +$4.84M | 0.08% | 286 |
|
|
2025
Q1 | $22.1M | Buy |
4,085,580
+378,135
| +10% | +$2.05M | 0.05% | 385 |
|
|
2024
Q4 | $27.6M | Buy |
3,707,445
+1,783,765
| +93% | +$13.3M | 0.06% | 344 |
|
|
2024
Q3 | $15.4M | Buy |
1,923,680
+1,633,468
| +563% | +$13.1M | 0.03% | 485 |
|
|
2024
Q2 | $2.52M | Sell |
290,212
-352,964
| -55% | -$3.07M | 0.01% | 877 |
|
|
2024
Q1 | $13.3M | Sell |
643,176
-31,648
| -5% | -$654K | 0.03% | 510 |
|
|
2023
Q4 | $15.6M | Buy |
674,824
+445,289
| +194% | +$10.3M | 0.04% | 451 |
|
|
2023
Q3 | $1.83M | Buy |
229,535
+188,274
| +456% | +$1.5M | ﹤0.01% | 950 |
|
|
2023
Q2 | $359K | Buy |
+41,261
| New | +$359K | ﹤0.01% | 1462 |
|
|
2023
Q1 | – | Sell |
-4,055
| Closed | -$14.2K | – | 2164 |
|
|
2022
Q4 | $14.2K | Buy |
+4,055
| New | +$14.2K | ﹤0.01% | 1832 |
|
|
2016
Q2 | – | Sell |
-35
| Closed | -$1K | – | 2116 |
|
|
2016
Q1 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 2012 |
|